Mannitol/proline - DNage

Drug Profile

Mannitol/proline - DNage

Alternative Names: D-mannitol/L-proline - DNage; Prodarsan

Latest Information Update: 12 May 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator DNage
  • Class Amino acids; Small molecules; Sugar alcohols
  • Mechanism of Action Antioxidants; Free radical scavengers; Oxygen radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cockayne syndrome
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cockayne syndrome

Most Recent Events

  • 31 Jan 2011 Discontinued - Phase-I for Cockayne syndrome in Netherlands (PO)
  • 31 Jan 2011 Discontinued - Preclinical for Cockayne syndrome in USA (PO)
  • 19 Jul 2010 DNage is no longer a wholly-owned subsidiary of Pharming Group
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top